Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a colleague
Right arrow Alert me to new issues of the journal
Right arrowRights & Permissions
Docetaxel, Cisplatin, and Trastuzumab As Primary Systemic Therapy for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced Breast Cancer
J Clin Oncol Hurley et al. 24: 1831

Publisher's Note

The April 20, 2006 article by Hurley et al, entitled “Docetaxel, Cisplatin, and Trastuzumab As Primary Systemic Therapy for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced Breast Cancer” (J Clin Oncol 24:1831–1838, 2006) was published online March 20, 2006 with an error. Jodeen E. Powell (Department of Surgery, University of Miami, Miami, FL) was inadvertently omitted from the author list. Corrections to the author list and Author Contributions section have been made as of June 19, 2006. No correction was needed to the Authors’ Disclosures of Potential Conflicts of Interest section.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a colleague
Right arrow Alert me to new issues of the journal
Right arrowRights & Permissions

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online